Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...

On the supply side, U.S. Energy Information Administration data on Wednesday showed U.S. crude inventories fell last week by ...

Crude futures rise on a 3.2M-barrel EIA draw. WTI trades above the long-term pivot and key moving averages, reinforcing a bullish oil outlook.

As rare earth magnet shortages threaten India’s EV and defence sectors, a little-known state-run firm, 75 years old, is ...

Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...

Oil pared gains on Thursday afternoon following a Reuters report that U.S. President Donald Trump's administration may allow Chevron to resume operations in Venezuela.Brent crude futures were up 26 ...

While unicorns and IPO-bound giants steal the spotlight, StartupMafia showcases emerging platforms tackling real-world problems with precision and innovation ...

Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization for general ...

HOUSTON (Reuters) -Oil prices rose on Thursday, lifted by expected cuts in Russian gasoline supply and optimism over U.S.

Altech Batteries Limited (ASX:ATC) (FRA:A3Y) (OTCMKTS:ALTHF) is pleased to announce an update on funding of the CERENERGY(R) sodium-chloride soli ...